Gestala (Chengdu) Technology Co., Ltd., registered September 2025 and publicly launched January 2026. Developing ultrasound brain-computer interfaces. Founder/CEO Phoenix Peng. Official July financing headline/body disagree (RMB430M versus RMB420M); retain the discrepancy.
Founded 2025
$— 2026-07-03 Meridian Capital Asia , C Capital , HongShan , Lens Technology , CEC Healthcare Fund , Sinovation Ventures , Lingang LKC Investment , Furong Investment , GoldTech VC , Dalton Venture , Seas Capital , TsingSong Capital , Gobi Partners CN¥150M 2026-03-12 Guosheng Capital , Dalton Venture , TsingSong Capital , Gobi Partners , Fourier Intelligence , Liepin , Seas Capital
SHOW MORE
team@apexlogos.ai · 10 hours ago
RELATED team@apexlogos.ai · 10 hours ago
BCI research snapshot, reviewed 2026-10-06. Company identity: Gestala. This is the pre-import evidence dossier; historical statements about database absence or review are archival. Unverified claims remain research leads, not validated facts.
Part 1/1
# Gestala
Research accessed: **2026-10-06**. Review draft; no database changes. Original source: user-pasted BCI.INTEL Company Tracker (47 entries).
## Identity and scope
Verified private company **Gestala (Chengdu) Technology Co., Ltd.** (company footer), [official site](https://www.gestala.com/ ). The site distinguishes registration on **2025-09-05** from formal founding announcement on **2026-01-01**. Headquarters established in **Chengdu on 2026-06-26**, with Shanghai headquarters announcement **2026-07-03**. Its ultrasound BCI platform remains a development programme: whole-brain communication, wearable/benchtop ultrasound and implantable technology should be described as pipelines rather than established approved clinical products. [Official news and positioning](https://www.gestala.com/ ); detailed news bodies and biographies are present in the [official application bundle](https://www.gestala.com/assets/app-dfjDHeJk.js ).
## Audit of pasted claims
| Pasted claim | Finding |
|---|---|
| Shenzhen HQ | Replace with current Chengdu / Shanghai company disclosures. |
| Phoenix Peng founder/CEO | Verified; Chinese name 彭雷. |
| $21.6M funding | Historical March 2026 round, incomplete after July follow-on. Retain original currency RMB150M. |
| Ultrasound BCI | Verified research direction, not proof of approved whole-brain read/write ability. |
| Active | 2026 financing and HQ announcements support operating status. |
## Investments and ownership
| Date | Amount / instrument | Investors / evidence |
|---|---|---|
| 2026-03-12 | **RMB150M angel equity**; announcement translation $21M, later $22M | Co-led **Guosheng Capital and Dalton Venture**; TsingSong Capital, Gobi Partners, Fourier Intelligence, Liepin, Seas Capital. [Founder announcement](https://www.linkedin.com/posts/phoenixpeng_im-thrilled-to-share-that-gestala-has-just-activity-7437688525245878272-GPMS ); official news/bundle above. |
| 2026-07-03 | **RMB420M Angel+**, translated $62M | Led **Meridian Capital Asia**; C Capital, HSG, Lens Technology, CEC Healthcare Fund, Sinovation Ventures, Lingang LKC Investment, Furong Investment, GoldTech VC; existing Dalton Venture, Seas Capital, TsingSong Capital and Gobi Partners. [Official release](https://www.gestala.com/news/22 ); [official embedded full release](https://www.gestala.com/assets/app-dfjDHeJk.js ). **China Renaissance was financial adviser, not an investor.** |
Two-round canonical sum **RMB570M**, company translation approximately $84M; do not sum inconsistent dollar conversions. **Conflict:** July 8 homepage headline says RMB430M while dated July 3 full round body says RMB420M. Retain RMB420M provisionally with review flag, do not create a third round. No acquisition, grant or public listing established.
## Founders and public team
| Person | Role and time basis | Profile / evidence | Direct profile-picture URL |
|---|---|---|---|
| Phoenix Peng, Ph.D. | Founder / CEO | [Official team](https://www.gestala.com/teams ); [actual team data/image resolver](https://www.gestala.com/assets/app-dfjDHeJk.js ) | https://media.licdn.com/dms/image/v2/D5603AQHKw3UfQPmLDw/profile-displayphoto-shrink_200_200/profile-displayphoto-shrink_200_200/0/1671951526509?e=2147483647&v=beta&t=BEpSMfPiBCdZth8hJejhaz9u2sV3bJd5fwryASGzMIE |
| Bashar W. Badran, Ph.D. | VP, Head of Clinical and Science | [Official team](https://www.gestala.com/teams ); [actual team data/image resolver](https://www.gestala.com/assets/app-dfjDHeJk.js ) | https://cdn.gestala.com/img/about/barsha.png |
| Ra'anan Gefen | VP of Implantable Technology | [Official team](https://www.gestala.com/teams ); [actual team data/image resolver](https://www.gestala.com/assets/app-dfjDHeJk.js ) | https://cdn.gestala.com/img/about/Raanan.jpg |
| David (Dudu) Rigler | VP Regulation and Quality | [Official team](https://www.gestala.com/teams ); [actual team data/image resolver](https://www.gestala.com/assets/app-dfjDHeJk.js ) | https://cdn.gestala.com/img/about/Dudu.jpg |
| Trevor Robbins, Ph.D. | Scientific advisory board | [Official team](https://www.gestala.com/teams ); [actual team data/image resolver](https://www.gestala.com/assets/app-dfjDHeJk.js ) | https://cdn.gestala.com/img/about/trevor.png |
| Jianfeng Feng, Ph.D. | Scientific advisory board | [Official team](https://www.gestala.com/teams ); [actual team data/image resolver](https://www.gestala.com/assets/app-dfjDHeJk.js ) | https://cdn.gestala.com/img/about/feng.png |
| Changjian Jiang | Advisor; Fudan associate professor | [Official team](https://www.gestala.com/teams ); [actual team data/image resolver](https://www.gestala.com/assets/app-dfjDHeJk.js ) | https://cdn.gestala.com/img/about/jiangjianchang.png |
## Company profile image
Logo: https://www.gestala.com/img/index/logo.svg ; alternative official `og:image`: https://cdn.gestala.com/img/index/logo.png . [Official homepage](https://www.gestala.com/ ). Individual team avatars were extracted from named objects and the CDN resolver in the official JavaScript bundle, rather than fabricated. Several other staff objects contain generic `avatar.png` placeholders and incomplete names; omit them from Person import.
## Adex match and review decision
No Org name match from read-only SQLite Gestala search. Proposed **Gestala**. Suitable for review; confirm RMB420M/430M discrepancy and registration versus founding-date semantics. Team biographies identify current executive/advisory roles; academic advisers should not be encoded as employees. No database changes.
Media validation 2026-10-06: the official SVG logo, CDN logo and Bashar Badran portrait returned image responses. The official CDN portraits for Gefen, Rigler, Robbins, Feng and Jiang returned HTTP 404; retain these discovered URLs as provenance, but do not import them as working portraits. Phoenix Peng’s CDN portrait also returned 404; the table instead saves his actual author portrait from his [self-authored financing announcement](https://www.linkedin.com/posts/phoenixpeng_im-thrilled-to-share-that-gestala-has-just-activity-7437688525245878272-GPMS ). LinkedIn asset URLs may expire. See the combined image audit for the final endpoint results. SHOW MORE
Bashar W. BadranVP, Head of Clinical and Science
Phoenix PengFounder / CEO